DTU Chemistry - PIPPI - About us

Advisory Board

Dr. Fritz Richter

Retired Vice President - Drug Product Development and General Manager AbbVie Germany GmbH & Co. KG.
Neckargemünd, Germany
mailto: Fritz Richter

Dr.Richter graduated in Pharmacy  at the University of Tübingen/Germany and received his Ph.D. in Pharmaceutical Chemistry at the University of Freiburg/Germany.
Prior to his retirement in early 2016 he worked more than 30 years in Research & Development  leadership positions in multinational pharmaceutical corporations. Companies he worked for are Sandoz/Novartis in Switzerland, Knoll/BASF Pharma in Germany and Abbott Laboratories in the US. Most recently he was Vice President Global Drug Product Development for AbbVie (the former research based pharma business of Abbott which became an independent company in 2013) and in addition General Manager of AbbVie’s R&D and Manufacturing site in Germany.

Professor Jette Sandholm Kastrup

Professor in structure-based drug design at University of Copenhagen.
Biostructural Research - www.ilf.ku.dk/forskning/biostruktur/
Department of Drug Design and Pharmacology
Faculty of Health and Medical Sciences
University of Copenhagen

Jette S. Kastrup is Professor in Structure-Based Drug Design and has been the leader of GluTarget, a project within the Programme of Excellence at the University of Copenhagen (2008-2013). Her primary research focus is on structural studies of ionotropic glutamate receptors in complex with agonists, antagonists, allosteric modulators and ions using X-ray crystallography. Recently, the group initiated studies by neutron macromolecular crystallography.
Prof. Kastrup received her MSc degree in Pharmacy in 1986 and obtained the PhD degree from the Royal Danish School of Pharmacy in 1988 within computational chemistry. During her following post doc period she moved into protein crystallography. Since 2008 she has been Professor (MSO) at the University of Copenhagen, and since 2015 a member of the Danish Council for Independent Research: Natural Sciences. 

Professor Christopher J Roberts

University of Delaware, US.           

Dr. Roberts is Professor and Director of the Center for Biomanufacturing Science and Technology in the Department of Chemical and Biomolecular Engineering at the University of Delaware (UD). He is the Director of the Biomolecular Interaction Technology Center, and a Co-Director of the Center for Pharmaceutical Development. He received a Bachelors of Chemical Engineering degree from UD, and a Ph.D. in Chemical Engineering from Princeton University. Prior to joining UD in 2002, he worked in the pharmaceutical industry as a formulation scientist. The Roberts laboratory focuses on fundamentals and applications of protein physical and chemical stability, (mis)folding, aggregation, kinetics, statistical mechanics, and thermodynamics to address questions of biopharmaceutical product design and manufacturing. 

Henrik Toft

Application Manager for Biomatics Technology.           

Henrik Toft has a strong background in multivariate analysis of spectroscopic and process data within research, development and process monitoring in major foodtech and pharmaceutical companies. Hand-on experience with spectroscopic techniques includes low- and high-field NMR, FT-IR and NIR. The resulting multivariate or multiway data have always been analysed using appropriate multivariate and multiway techniques both as developer of new methods as well as end-user of commercial software. Applications range from research within metabolic profiling to instrument and application development for quantitative and qualitative applications in the food industry. Most recently multivariate process monitoring of large scale biopharmaceutical batch production processes have been added to the list of applications.

Jens Bukrinski

Senior Advisor, CEO - CMC assist ApS.

Jens Bukrinski is Senior advisor at CMC Assist ApS. and hold a MSc in Dairy Science and technology and a PhD in structural biology. He worked eight years in academia within structural and biophysical characterization of proteins and peptides as post doc at University of Copenhagen and later as research associate professor at Carlsberg Laboratories. Following his academic carrier he moved into drug development and during his seven years at Novo Nordisk A/S and six years at Novozymes A/S, Biopharma R&D he covered preformulation, formulation and analytical development as well as regulatory science within protein and peptide based drugs for the treatment hemophilia, diabetes, obesity, growth defects and autoimmune diseases. Jens has furthermore gained extensive experience with application development of modern excipients and advanced drug delivery systems. In 2016 he founded CMC Assist ApS providing independent counseling to pharma, biotech and related industries within regulatory documentation and CMC development.